MUSKEGON, MI — Trinity Health’s hospitals in Muskegon and Grand Rapids are the first in West Michigan to offer the Inspire implant to patients with moderate to severe obstructive sleep apnea.
The newest version of the implant, Inspire V, is approved by the U.S. Food and Drug Administration and improves upon previous versions of Inspire with a more simplified procedure, enhanced patient comfort settings and more efficient patient management.
Inspire V is recommended for patients who have not responded well to Continuous Positive Airway Pressure (CPAP) treatment. While CPAP is still the first-line therapy for obstructive sleep apnea, about 50% of patients struggle with using the device, Dr. Craig Hoekzema, an otolaryngologist with West Shore ENT & Allergy, said…